• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2024年5月贝尔格莱德人群对麻疹、腮腺炎和风疹病毒的群体免疫

Herd Immunity to the Measles, Mumps and Rubella Viruses Among the Belgradian Population in May, 2024.

作者信息

Popova Anna Y, Smirnov Vyacheslav S, Egorova Svetlana A, Dragačević Luka, Milichkina Angelica M, Protić Jelena, Danilova Ekaterina M, Drozd Irina V, Petrušić Marija, Zhimbaeva Ojuna B, Glazkova Elizaveta S, Gutić Nataša, Ivanov Valeri A, Ramsay Edward S, Kotsar Oleg V, Smolensky Vyacheslav Y, Totolian Areg A

机构信息

Federal Service for the Oversight of Consumer Protection and Welfare,127994 Moscow, Russia.

Saint Petersburg Pasteur Institute, 197101 St. Petersburg, Russia.

出版信息

Vaccines (Basel). 2025 Jun 18;13(6):652. doi: 10.3390/vaccines13060652.

DOI:10.3390/vaccines13060652
PMID:40573983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12199194/
Abstract

In the Republic of Serbia, measles vaccination was first introduced in 1971, while combined vaccination (measles, mumps, rubella) was made mandatory in 1996 as part of the national vaccination program. Reported prevalence values for 2023 were <0.75 cases per 100K population for measles, 0.09 cases per 100K for mumps, and no cases of rubella. : This cross-sectional study was performed in May, 2024 as part of the project "Herd Immunity to Vaccine-Preventable and Other Relevant Infections in the Belgradian Population." It focused on assessing herd immunity to measles, mumps and rubella (MMR) among residents insofar as these remain a public concern despite the availability of vaccines. A total of 2533 subjects were distributed across nine age groups, covering those aged 1-70 years and various professional groups residing in Belgrade. Participants were stratified by age and activity. Upon obtaining individual information by online questionnaire and receiving a signed statement of informed consent, blood samples were obtained for IgG antibody testing (ELISA) to determine MMR serological status. The results were compared to national and international immunization standards to evaluate herd immunity levels. : Our results indicate varying levels of immunity for each virus, with specific demographic groups showing different immunity levels. Total measles seroprevalence during this study was 74.7%, with significant variation across all age groups. While high seropositivity was observed in both children (90.7%) and elder age groups (98.4%), middle-aged individuals in the age group 30-49 years showed significantly lower IgG levels. Between 2021 and 2023, there were no registered cases of rubella detected in Serbia, which indicates a high level of immunity. This was confirmed here with consistently high IgG levels across all age groups, with an average seropositivity of 94.8%. Average mumps seropositivity across all age groups was 85.1%. The lowest value was in the young child (1-5 years) age group (76.1%); the highest was in the elderly group (92.6%). : The current findings suggest that the Belgradian population has strong overall immunity to MMR, yet with some concerns regarding measles immunity in middle-aged adults, suggesting a potential need for catch-up vaccinations. While rubella status indicates strong herd immunity and minimal risk of outbreaks, mumps immunity in some groups (children, middle-aged adults) is below the protective threshold. While it is still sufficient to prevent widespread transmission, it should be closely observed. To our knowledge, this study is the first of its kind to provide data about MMR seroprevalence in Belgrade. Findings indicate the need for constant surveillance and revaccination of vulnerable/seronegative groups.

摘要

在塞尔维亚共和国,麻疹疫苗接种于1971年首次引入,而联合疫苗接种(麻疹、腮腺炎、风疹)于1996年成为国家疫苗接种计划的一部分并强制实施。2023年报告的患病率为:麻疹每10万人口<0.75例,腮腺炎每10万人口0.09例,风疹无病例。:这项横断面研究于2024年5月进行,是“贝尔格莱德人群对疫苗可预防及其他相关感染的群体免疫”项目的一部分。该研究重点评估居民对麻疹、腮腺炎和风疹(MMR)的群体免疫情况,因为尽管有疫苗可用,但这些疾病仍然是公众关注的问题。共有2533名受试者分布在九个年龄组中,涵盖1至70岁的人群以及居住在贝尔格莱德的不同职业群体。参与者按年龄和活动进行分层。通过在线问卷获取个人信息并收到知情同意书签名声明后,采集血样进行IgG抗体检测(ELISA)以确定MMR血清学状态。将结果与国家和国际免疫标准进行比较,以评估群体免疫水平。:我们的结果表明,每种病毒的免疫水平各不相同,特定人群显示出不同的免疫水平。本研究期间麻疹总血清阳性率为74.7%,各年龄组差异显著。虽然儿童(90.7%)和老年组(98.4%)的血清阳性率较高,但30至49岁的中年个体的IgG水平显著较低。2021年至2023年期间,塞尔维亚未检测到风疹登记病例,这表明免疫水平较高。所有年龄组的IgG水平持续较高,平均血清阳性率为94.8%,证实了这一点。所有年龄组的腮腺炎平均血清阳性率为85.1%。最低值出现在幼儿(1至5岁)年龄组(76.1%);最高值出现在老年组(92.6%)。:目前的研究结果表明,贝尔格莱德人群对MMR具有较强的总体免疫力,但中年成年人的麻疹免疫力存在一些问题,这表明可能需要进行补种疫苗。虽然风疹状况表明群体免疫力强且爆发风险最小,但某些群体(儿童、中年成年人)的腮腺炎免疫力低于保护阈值。虽然这仍然足以防止广泛传播,但应密切观察。据我们所知,这项研究是同类研究中第一项提供贝尔格莱德MMR血清阳性率数据的研究。研究结果表明需要对弱势群体/血清阴性群体进行持续监测和重新接种疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/12199194/857359ddb64b/vaccines-13-00652-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/12199194/0f3d50351767/vaccines-13-00652-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/12199194/c4b5612bd8e3/vaccines-13-00652-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/12199194/648e1285ac54/vaccines-13-00652-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/12199194/a6dc11bdb929/vaccines-13-00652-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/12199194/62c9ebb3a1b8/vaccines-13-00652-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/12199194/b305cfa032f4/vaccines-13-00652-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/12199194/857359ddb64b/vaccines-13-00652-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/12199194/0f3d50351767/vaccines-13-00652-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/12199194/c4b5612bd8e3/vaccines-13-00652-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/12199194/648e1285ac54/vaccines-13-00652-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/12199194/a6dc11bdb929/vaccines-13-00652-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/12199194/62c9ebb3a1b8/vaccines-13-00652-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/12199194/b305cfa032f4/vaccines-13-00652-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/12199194/857359ddb64b/vaccines-13-00652-g007.jpg

相似文献

1
Herd Immunity to the Measles, Mumps and Rubella Viruses Among the Belgradian Population in May, 2024.2024年5月贝尔格莱德人群对麻疹、腮腺炎和风疹病毒的群体免疫
Vaccines (Basel). 2025 Jun 18;13(6):652. doi: 10.3390/vaccines13060652.
2
Vaccines for measles, mumps, rubella, and varicella in children.儿童麻疹、腮腺炎、风疹和水痘疫苗。
Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD004407. doi: 10.1002/14651858.CD004407.pub5.
3
Parents' and informal caregivers' views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence.父母及非正式照料者关于儿童常规疫苗接种沟通的观点与经历:定性证据综述
Cochrane Database Syst Rev. 2017 Feb 7;2(2):CD011787. doi: 10.1002/14651858.CD011787.pub2.
4
Vaccines for measles, mumps and rubella in children.儿童麻疹、腮腺炎和风疹疫苗。
Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD004407. doi: 10.1002/14651858.CD004407.pub3.
5
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
6
Modeling Reemergence of Vaccine-Eliminated Infectious Diseases Under Declining Vaccination in the US.美国疫苗接种率下降情况下疫苗可消除传染病再度出现的模型构建
JAMA. 2025 Apr 24. doi: 10.1001/jama.2025.6495.
7
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.

引用本文的文献

1
Mumps Epidemiology in the Autonomous Province of Vojvodina, Serbia: Long-Term Trends, Immunization Gaps, and Conditions Favoring Future Outbreaks.塞尔维亚伏伊伏丁那自治省的腮腺炎流行病学:长期趋势、免疫缺口及利于未来疫情爆发的条件
Vaccines (Basel). 2025 Aug 6;13(8):839. doi: 10.3390/vaccines13080839.

本文引用的文献

1
Collective Immunity to the Measles, Mumps, and Rubella Viruses in the Kyrgyz Population.吉尔吉斯斯坦人群对麻疹、腮腺炎和风疹病毒的群体免疫
Vaccines (Basel). 2025 Feb 27;13(3):249. doi: 10.3390/vaccines13030249.
2
Infectious Disease Prophylaxis During and After Immunosuppressive Therapy.免疫抑制治疗期间及之后的传染病预防
Kidney Int Rep. 2024 Apr 25;9(8):2337-2352. doi: 10.1016/j.ekir.2024.04.043. eCollection 2024 Aug.
3
Measles again?又是麻疹?
Med Clin (Barc). 2024 Oct 18;163(7):344-346. doi: 10.1016/j.medcli.2024.05.021. Epub 2024 Aug 16.
4
An Alarming Emergence of Measles in Europe: Gaps and Future Directions.欧洲麻疹疫情令人担忧地出现:差距与未来方向
Balkan Med J. 2024 Sep 6;41(5):321-323. doi: 10.4274/balkanmedj.galenos.2024.060824. Epub 2024 Aug 16.
5
Measles Outbreak in Socioeconomically Diverse Sections: A Review.社会经济多元化地区的麻疹疫情:综述
Cureus. 2024 Jun 21;16(6):e62879. doi: 10.7759/cureus.62879. eCollection 2024 Jun.
6
The impact of temperature, humidity and closing school on the mumps epidemic: a case study in the mainland of China.温度、湿度和停课对流行性腮腺炎疫情的影响:中国大陆的一项病例研究。
BMC Public Health. 2024 Jun 19;24(1):1632. doi: 10.1186/s12889-024-18819-w.
7
Waning of Humoral Immunity to Vaccine-Preventable Diseases in Children Treated for Acute Lymphoblastic Leukemia: A Single-Center Retrospective Cross-Sectional Analysis.儿童急性淋巴细胞白血病治疗后疫苗预防疾病的体液免疫减弱:单中心回顾性横断面分析。
Turk J Haematol. 2024 Aug 28;41(3):160-166. doi: 10.4274/tjh.galenos.2024.2024.0150. Epub 2024 May 27.
8
Questionable Immunity to Mumps among Healthcare Workers in Italy-A Cross-Sectional Serological Study.意大利医护人员对腮腺炎的可疑免疫力——一项横断面血清学研究
Vaccines (Basel). 2024 May 10;12(5):522. doi: 10.3390/vaccines12050522.
9
Immunity against measles, mumps, rubella, and varicella among homeless individuals in Germany - A nationwide multi-center cross-sectional study.德国无家可归者的麻疹、腮腺炎、风疹和水痘免疫状况 - 一项全国多中心横断面研究。
Front Public Health. 2024 May 9;12:1375151. doi: 10.3389/fpubh.2024.1375151. eCollection 2024.
10
Measles matter: Recent outbreaks highlight the need for catch-up vaccination in Europe and around the globe.麻疹问题:近期疫情凸显欧洲及全球补种疫苗的必要性。
New Microbes New Infect. 2024 Mar 16;58:101238. doi: 10.1016/j.nmni.2024.101238. eCollection 2024 Apr.